Clinical Trial Update: Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT [NA]

View source ↗

Summary

A terminated randomized trial evaluating the combination of low molecular weight heparin and aspirin for recurrent pregnancy loss associated with antiphospholip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Pregnancy Loss

Drugs mentioned

• Aspirin (Aspirin)
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Recurrent Pregnancy Loss, Antiphospholipid Antibody Syndrome | NA | Status: TERMINATED